This is a company that has consistently delivered strong results, one quarter after another, and over the last year they haven't gotten credit for it.

The turmoil in the boardroom and the goings-on with the CEO succession should dominate the agenda.

If J&J is not willing to up their bid, I think Guidant will be going to Boston Scientific.

I think there's always going to be a group of people who are willing to do that, especially as you get more empty nesters. In those households, the pet takes on incredible importance as a member of the family and people are willing to shell out incredible amounts of money to keep them healthy.

It's just a lot more certain. It's a bird in the hand, and better than two birds in the bush.

There is so much uncertainty involved. You just have a wild card pretty much everywhere you look.